Interferon Signature Genes in Early Diagnosis of Systemic Lupus Erythematosus: Current Value and Limitations
Systemic lupus erythematosus (SLE) is a highly heterogeneous autoimmune disease, and early diagnosis remains a major clinical challenge. Abnormal activation of the type I interferon (IFN) pathway is one of the core mechanisms in the pathogenesis of SLE. The IFN signature, as a biomarker reflecting activation of this pa...